Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease (Q35987805)

11 August 2017

1 reference

title

Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease (English)

1 reference

11 August 2017

M Florencia Delgado

1 reference

11 August 2017

Fernando P Polack

series ordinal

1 reference

11 August 2017

publication date

1 December 2004

1 reference

Expert Review of Vaccines

11 August 2017

published in

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

11 August 2017

page(s)

693-700

1 reference

Bronchiolitis-associated hospitalizations among US children, 1980-1996.

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Respiratory syncytial virus infection in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Respiratory syncytial virus infection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Respiratory Syncytial Virus Infections within Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

A role for immune complexes in enhanced respiratory syncytial virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

Cell-mediated Immunity to Respiratory Syncytial Virus Induced by Inactivated Vaccine or by Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.3.6.693

21 January 2018

Identifiers

DOI

10.1586/14760584.3.6.693

1 reference

11 August 2017

1 reference